MARKET

SGMO

SGMO

SANGAMO THERAPEU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.37
-0.12
-1.85%
After Hours: 6.30 -0.07 -1.10% 18:29 03/31 EDT
OPEN
6.51
PREV CLOSE
6.49
HIGH
6.60
LOW
6.16
VOLUME
2.40M
TURNOVER
--
52 WEEK HIGH
13.91
52 WEEK LOW
4.810
MARKET CAP
739.06M
P/E (TTM)
-7.2917
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SGMO stock price target is 20.67 with a high estimate of 36.00 and a low estimate of 10.00.

EPS

SGMO News

More
  • 3 Top Stocks You've Probably Never Heard Of
  • MotleyFool.com · 3d ago
  • Stocks To Watch: Investors Stay The Distance
  • Seeking Alpha - Article · 3d ago
  • Sangamo Therapeutics: Market Cap Is At A Bargain Relative To Its Cash Position
  • Seeking Alpha - Article · 6d ago
  • Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?
  • MotleyFool.com · 03/23 13:27

Industry

Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About SGMO

Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The Company has clinical and preclinical programs in development and partnered certain programs with biopharmaceutical companies to expedite clinical and commercial development. The focus for its Company is the development of human therapeutics. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. The Company has initiated a Phase I/II clinical trial evaluating its zinc finger nuclease (ZFN) in vivo genome editing approach for the treatment of hemophilia B. In the development of its ZFP technology platform, it is focusing its resources on product development for therapeutic use in humans and on its non-therapeutic applications.
More

Webull offers kinds of Sangamo Therapeutics Inc stock information, including NASDAQ:SGMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGMO stock news, and many more online research tools to help you make informed decisions.